l carnitine deficiency test Transporter – Role of carnitine in disease

While CAR-T therapy has demonstrated remarkable efficacy in hematologic malignancies such as multiple myeloma and relapsed/refractory B-cell lymphoproliferative disorders (leukemias, lymphomas) ( Figure 1 To overcome the antigen selection hurdle, significant research focuses on identifying neoantigens and unique splice variants arising from genomic alterations and aberrant RNA splicing in tumors

Direct supplementation of cysteine can induce rapid elevations in highly cytotoxic hydrogen sulfide levels

Mobasheri, A

scale-up does not change the upstream production processes 82,85

Naranmandura et al., 2012a), thereby inducing cytotoxicity in normal cells